MedTrace Logo

evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)

NCT02932592 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2022-05-26

No results posted yet for this study

Summary

To evaluate the glycemic variations during acute coronary syndrome in non-diabetic patients (euglycemic, or with impaired fasting glucose, or with impaired glucose tolerance)

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

Continuous Glucose Monitoring System (i Pro 2 - Medtronic)

This device can register blood glucose values and excursions. This device consists of a needle (applied in subcutaneous way) and of a recording device.

Sponsors & Collaborators

  • University of Pavia

    lead OTHER

Principal Investigators

  • Giuseppe Derosa, MD, PhD, FESC · University of Pavia

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-16
Primary Completion
2017-03-25
Completion
2017-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02932592 on ClinicalTrials.gov